2026–2027 Flu, COVID, and RSV Information
Walk-In Flu Clinic Information
We currently have injectable flu vaccine and FluMist available. We offer walk-in flu clinics for our established patients on Saturdays in October 2026 from 9:00 AM to 12:00 PM. These clinics are for flu vaccination only and are available to patients ages 6 months and older.
Planned clinic dates: October 3, 10, 17, 24, and 31
Dates and hours have not yet been finalized and are subject to change. Please check this page before coming.
Flu vaccines may also be given during scheduled well visits or nurse appointments.
COVID-19 vaccine is not currently available. We will update this page when availability changes.
RSV preventive antibody will be available beginning October 1 for eligible infants and children. RSV immunizations require a scheduled well visit or nurse appointment and will not be offered during walk-in flu clinics.
| Immunization | Availability |
|---|---|
| Flu shot | Available |
| FluMist nasal spray | Available |
| COVID-19 vaccine | Not currently available |
| RSV preventive antibody | Available beginning October 1 for eligible infants and children |
Influenza Vaccine Information
Annual flu vaccination is recommended for everyone ages 6 months and older. For most people, September or October is the ideal time to receive the vaccine, although vaccination should continue throughout the flu season.
Some children ages 6 months through 8 years need two doses during the same flu season. This generally applies when a child has not previously received at least two flu vaccine doses or when their vaccination history is unknown. The two doses must be given at least four weeks apart. We will review your child’s vaccination history and let you know how many doses are needed.
We currently offer both the injected flu vaccine and FluMist nasal spray. FluMist is an option for eligible patients ages 2 years and older, but it is not appropriate for every child. Our clinical staff will help determine which option is appropriate.
A vaccine-only appointment does not include an evaluation of illness or other medical concerns. If your child is sick or needs to discuss another concern, please call the office to schedule an appropriate visit.
Respiratory Syncytial Virus (RSV) Information
What is RSV?
RSV is a common respiratory virus that usually causes cold-like symptoms. In infants, however, RSV can sometimes cause serious lung infections, including bronchiolitis and pneumonia. RSV is a leading cause of hospitalization among infants in the United States.
What is the infant RSV preventive antibody?
Long-acting RSV antibodies help protect infants from severe RSV illness and hospitalization. The two available products are nirsevimab (Beyfortus) and clesrovimab (Enflonsia). The product used may depend on the child’s age, eligibility, and availability.
These antibodies are not vaccines. Instead of stimulating the immune system to produce antibodies, they provide protective antibodies directly. They are given as an injection and provide protection for at least five months—approximately the length of a typical RSV season.
Who should receive an infant RSV antibody?
An infant RSV antibody is recommended for babies younger than 8 months who are born during or entering their first RSV season when
The pregnant parent did not receive an RSV vaccine during pregnancy
The parent’s RSV vaccination status is unknown
The baby was born fewer than 14 days after the parent received the RSV vaccine.
Most babies born 14 or more days after maternal RSV vaccination do not also need an infant RSV antibody.
Babies born during RSV season—generally October through March—should ideally receive the antibody during their first week of life. It may be administered during a well-child visit or scheduled nurse appointment. Eligible babies born before RSV season should generally receive it shortly before the season begins. Some children ages 8 through 19 months who are at increased risk of severe RSV disease may qualify for protection during their second RSV season. Only certain children meet these criteria, and the available antibody options differ for this age group. Please ask your child’s clinician whether your child is eligible.
Availability at NWCP
We will begin administering infant RSV preventive antibody on October 1. It will be available to eligible established patients during scheduled well-child visits or nurse appointments. It will not be offered during walk-in flu clinics. For questions about your child’s eligibility, please call our office or send us a message through MyChart.
COVID-19 Vaccination
We do not currently have COVID-19 vaccine available. We will update this page when availability changes.
For the 2026–2027 season, the American Academy of Pediatrics recommends COVID-19 vaccination for:
• All children ages 6 through 23 months.
• Children and adolescents ages 6 months through 18 years who are moderately or severely immunocompromised.
• Children ages 2 through 18 years who have risk factors for severe COVID-19, live in a congregate setting, have never received a COVID-19 vaccine, or live with someone at increased risk for severe illness.
Children ages 2 through 18 years without these risk factors may also receive the updated vaccine if their parent or guardian would like them to have COVID-19 protection.
The number of doses needed depends on the child’s age, health, and previous COVID-19 vaccinations. Please discuss your child’s individual vaccination needs with their clinician.
COVID-19 Testing and Sick Visits
We continue to offer rapid antigen and PCR COVID-19 testing in our office.
Established patients with symptoms may schedule a sick visit or use our regular sick walk-in hours. Please see our Hours and Contact page for the current schedule. If you would like to see a specific clinician, please call the office to schedule an appointment.
For medical questions, please call our office or send us a message through MyChart.